India is poised to capture a bigger share of the global pharmaceutical manufacturing market beyond generics, according to a report by Boston Consulting Group (BCG). Trump-Modi Meet The mega MIGA, MAGA ...

Fibonacci offers specialized software and services to financial institutions Fibonacci’s revenue will now succeed €210 million Equinox has acquired Quid Group in 2019 Fibonacci Group ...